MACSF

Mutuelle d'Assurance du Corps de Santé Français (MACSF) is an insurance provider dedicated to health professionals in France, founded in 1935. It serves approximately 950,000 members across various medical and paramedical specialties, offering a range of professional and personal insurance solutions, as well as services related to savings, financing, and pensions. MACSF's products are designed to meet the evolving needs of its members, supporting them throughout their professional journeys and personal projects.

Stéphane Dessirier

Managing Director and Chairman of the Executive Committee

Philippe Eveilleau

President and Director, MACSF Retirement Savings

Nicolas Gombault

Deputy Managing Director and Member of the Executive Committee

13 past transactions

Hoopcare

Seed Round in 2022
Surgical Pre-evaluation My name is Yassine Moussali, I'm a french anesthesiologist and CEO of a early-stage start-up called Intelligence Anesthesia. We aim to develop a premium software to automatically evaluate patients before a surgery. Associated to this project are Nicolas Bonifas, specialist in computer science and artificial intelligence at IBM and David Chaudeurge engineer and CFO. Surgical pre-evaluation is an important and complex step, evolving with new guidelines and new protocols. My thesis on pre-anesthetic evaluation associated with the arrival of Nicolas Bonifas, positions us as one of the rare team specialized in this field in Europe. The benefits of a high-quality assessment are certain, confirmed by the American Society of Anesthesiology: time-saving process, efficiency, improved security, higher users and patients satisfaction...

Invivox

Series A in 2022
Invivox is an innovative online platform that connects medical professionals for practical, in situ training sessions, primarily in small groups or one-on-one settings. By facilitating these interactions among doctors worldwide, Invivox aims to enhance medical education and ultimately improve patient care. The platform not only offers interactive online classes but also publishes weekly medical magazines and curates specialized training opportunities in collaboration with a network of international experts. Through these initiatives, Invivox democratizes access to knowledge in the healthcare sector, providing valuable mentorship across various medical specialties.

Synapse Medicine

Series B in 2022
Synapse Medicine is a company based in Bordeaux, France, founded in 2017, that develops an online platform aimed at assisting healthcare professionals, including doctors and pharmacists. The platform provides reliable and up-to-date information about medications, allowing users to analyze prescriptions in real-time and enhance the safety of drug therapies. By offering access to critical medical intelligence, Synapse Medicine enables healthcare providers to make informed decisions and ensure better outcomes for patients through virtual medical assistance.

Resilience

Series A in 2022
Resilience Care is building a software-based solution for cancer treatment providers and patients.

Wandercraft

Series C in 2022
Wandercraft SAS, founded in 2012 and based in Paris, France, specializes in the development of exoskeleton technology aimed at patients with mobility limitations due to spinal cord injuries, neuromuscular diseases, and strokes. The company's flagship product, Atalante, is a self-balancing, hands-free exoskeleton designed for rehabilitation in health centers, allowing users to walk without the need for crutches or additional technical aids. CE-marked in 2019, Atalante is sold to European rehabilitation hospitals to enhance gait re-learning treatments. Additionally, Wandercraft is working on a more compact exoskeleton for personal mobility in everyday life. The company integrates expertise in areas such as robotics, artificial intelligence, and clinical applications, making it a pioneer in creating realistic, autonomous walking devices for individuals with walking impairments.

Lifen

Series C in 2021
Lifen is a healthcare data management platform that facilitates secure communication between health professionals. The company provides a mail assistant that generates secure medical email addresses, reduces paper mail costs, and automates the identification of available communication methods for correspondents. By streamlining medical communication, Lifen enables healthcare practitioners to share and analyze medical data efficiently and securely. The company operates in compliance with regulations and guidelines set by relevant authorities, acting as a subcontractor to physicians or healthcare facilities without owning the data it hosts.

Ledger

Series C in 2021
Ledger develops security and infrastructure solutions for cryptocurrencies as well as blockchain applications for individuals and companies, by leveraging a distinctive, proprietary technology. Launched in 2014, Ledger has designed an acclaimed line of hardware security devices quickly placing the company as a global leader on the market with 1,000,000 units sold in more than 165 countries. For enterprises and corporations, Ledger introduced the Vault: a fully managed SaaS solution addressing the need to safeguard a very large amount of multiple cryptocurrencies while mitigating both IT and physical assault threats. The company is also active on the industrial IoT market, leveraging its secure hardware technology to interface sensors and machines to smart contracts or blockchain based assets. Ledger is headquartered in Paris, has a production facility in Vierzon (France) and offices in San Francisco.

Savana

Series B in 2020
Savana is a developer of an AI-based electronic health record platform focused on enhancing medical record management. The company's technology utilizes deep learning techniques to analyze unstructured text within electronic health records, allowing for the automatic extraction of valuable medical information. This capability supports medical professionals by improving clinical research and precision medicine, effectively unlocking the full clinical value contained within electronic records. Through its innovative approach, Savana aims to streamline the management of health information and enhance the quality of care provided to patients.

Gleamer

Series A in 2020
Gleamer SAS is a Paris-based company founded in 2017 that specializes in artificial intelligence software designed for medical imaging diagnosis. Its flagship product, BoneView, utilizes AI technology to automatically detect traumatic injuries and bone abnormalities in radiographic images. This software assists radiologists by providing preliminary data for diagnosis, highlighting potential lesions, and improving overall productivity in clinical settings. By integrating this technology into hospitals and clinics, Gleamer aims to enhance the accuracy and efficiency of radiological assessments, enabling radiologists to prioritize patients effectively and reduce the risk of overlooking critical conditions.

Synapse Medicine

Venture Round in 2020
Synapse Medicine is a company based in Bordeaux, France, founded in 2017, that develops an online platform aimed at assisting healthcare professionals, including doctors and pharmacists. The platform provides reliable and up-to-date information about medications, allowing users to analyze prescriptions in real-time and enhance the safety of drug therapies. By offering access to critical medical intelligence, Synapse Medicine enables healthcare providers to make informed decisions and ensure better outcomes for patients through virtual medical assistance.

Owkin

Series A in 2020
Owkin is an artificial intelligence company founded in 2016, with headquarters in New York and an additional office in Paris. The company focuses on developing machine learning software for medical research, enabling researchers to test AI models on distributed data. Owkin's offerings include Owkin Lab, which facilitates data connectivity by therapeutic area; Owkin Loop, which provides validated and packaged models; and a comprehensive software stack for full-stack services. The company currently has 30 live models and an additional 40 in development. Owkin aims to empower medical researchers in hospitals, universities, and pharmaceutical companies to better understand variations in drug efficacy among patients, enhance the drug development process, and identify optimal treatments for individual patients, ultimately improving treatment outcomes. The company is supported by various investors and has a scientific board to guide its research initiatives.

Wellium

Venture Round in 2020
Wellium SAS, established in 2016 and headquartered in Levallois-Perret, France, specializes in digital transformation tools for the medical sector. The company provides teleconsultation solutions aimed at improving healthcare access and efficiency. Its flagship products include Feelae, an application that enables patients to receive medical care remotely, addressing issues such as medical desertification and overcrowding in emergency services, and Leah, a teleconsultation platform designed specifically for healthcare professionals to consult with their patients online. Through these innovations, Wellium aims to enhance the overall healthcare experience for both patients and doctors.

BitFury

Venture Round in 2018
BitFury is a prominent full-service blockchain technology company and a significant private infrastructure provider within the blockchain ecosystem. The company specializes in developing and delivering both software and hardware solutions designed to facilitate secure asset movement across the blockchain. Its offerings include custom semiconductor chips and mobile data centers, which enhance the security and infrastructure of organizations using private blockchain networks. By providing these comprehensive solutions, BitFury supports businesses, governments, and individuals in leveraging blockchain technology effectively and securely.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.